Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylene blue for outpatient COVID-19
IRCT20220211053993N1Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of methylene blue in coronavirus disease 2019 (COVID-19), sponsored by Mashhad University of Medical Sciences. Primary endpoints: Oxygen pressure saturation, Respiratory rate and 10 more. Started Jun 2022; status: completed.
02
Drugs
methylene blue
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on IRCT20220211053993N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220211053993N1.